NCT01824446View on ClinicalTrials.gov

AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

May 29, 2013

Study Completion Date

May 29, 2013

Conditions

Healthy

Interventions

DRUG

Radiolabeled SPD602 (FBS0701, SSP-004184)

A single oral dose of 3g of radio-labelled SSP-004184 on Day 1

Trial Locations (1)

53704

Covance Clinical Research Unit Inc, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Shire

INDUSTRY

NCT01824446 - AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184 | Biotech Hunter | Biotech Hunter